SILENCE THER. (SLN)

 
Due to recent changes by the London Stock Exchange relating to MiFID II, some AIM stocks are trading off‑book and therefore not showing recent prices, price changes or trades. We are working with the LSE to improve this situation.

SLN Share PerformanceMore

52 week high254.75 23/10/17
52 week low71.90 03/05/17
52 week change 75.25 (65.43%)
4 week volume1,058,005 29/10/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Silence Therapeutics provides litigation update

Silence Therapeutics said it has served is defense in actions initiated by Alnylam and The Medicines Company. Previously, ...

Update on litigation matters

RNS Number: 8685W Silence Therapeutics PLC 20 November 2017 Update on litigation matters 20 November 2017 Silence Therapeutics plc, AIM:SLN ("Silence" or "the Company") a leader in the discovery, delivery, and development of novel RNA therapeutics for the treatment of serious diseases with unmet medical need, announces an update on litigation matters. P...

Capital Markets Day

RNS Number: 3663W Silence Therapeutics PLC 14 November 2017 Silence Therapeutics ' 2017 Capital Markets Day 14 November 2017 Silence Therapeutics plc, AIM:SLN ("Silence" or "the Company") a leader in the discovery, delivery, and development of novel RNA therapeutics for the treatment of serious diseases with unmet medical need, will today host a Capital M...

Silence Therapeutics provides litigation update

Silence Therapeutics expressed confidence that it would emerge successfully from litigation in the UK over a patent disput...

Update on Litigation Matters

RNS Number: 4621V Silence Therapeutics PLC 03 November 2017 Update on litigation matters 3 November 2017 Silence Therapeutics plc, AIM:SLN ("Silence" or "the Company") a leader in the discovery, delivery, and development of novel RNA therapeutics for the treatment of serious diseases with unmet medical need, announces an update on litigation matters. Pre...

Second Price Monitoring Extn

RNS Number: 4487V Silence Therapeutics PLC 02 November 2017 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more than a pre-deter...

Price Monitoring Extension

RNS Number: 4474V Silence Therapeutics PLC 02 November 2017 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the e...

Holding(s) in Company

RNS Number: 6933U Silence Therapeutics PLC 26 October 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Silence Ther...

Fundamental DataMore

EPS-12.1
Dividend yield0 %

Latest discussion posts More

  • Re: Slow decline.

    Hi, Totally agree and I am not sure why apart from just general lack of interest. The attached might help cheer you up a ...
    27-Apr-2017
    tallyfox
  • Slow decline.

    Feels like death by a thousand cuts at the moment. What's it going to take to reverse this decline?
    27-Apr-2017
    rikid

Users' HoldingsMore

Users who hold SILENCE THER. also hold..
LLOYDS GRP.36%
BP26%
ROYAL BANK SCOT21%
TESCO21%
BARCLAYS18%

Codes & Symbols

ISINGB00B9GTXM62
SymbolsSLN, LSE:SLN, SLN.L, SLN:LN, LON:SLN, XLON:SLN

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account